Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Fagin

Showing results (171-180 of 261) with videos related to

Pageof 27
Sort By:
BMC Genomics|April 26, 2012
Genome-wide analysis of Pax8 binding provides new insights into thyroid functionsSergio Ruiz-Llorente, Enrique Carrillo Santa de Pau, Ana Sastre-Perona, et al.
Cancer Discovery|February 1, 2013
Relief of feedback inhibition of HER3 transcription by RAF and MEK inhibitors attenuates their antitumor effects in BRAF-mutant thyroid carcinomasCristina Montero-Conde, Sergio Ruiz-Llorente, Jose M Dominguez, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 2012
STAT3 negatively regulates thyroid tumorigenesisJoana Pinto Couto, Laura Daly, Ana Almeida, et al.
Oncogene|August 16, 2024
Cooperative genomic lesions in HRAS-mutant cancers predict resistance to farnesyltransferase inhibitorsAradhya Nigam, Gnana P Krishnamoorthy, Walid K Chatila, et al.
The Journal of Clinical Endocrinology and Metabolism|April 2, 2013
Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancyIan Ganly, Julio Ricarte Filho, Stephanie Eng, et al.
Thyroid : Official Journal of the American Thyroid Association|November 12, 2014
Thyrotropin suppression increases the risk of osteoporosis without decreasing recurrence in ATA low- and intermediate-risk patients with differentiated thyroid carcinomaLaura Y Wang, Andrew W Smith, Frank L Palmer, et al.
The Journal of Clinical Endocrinology and Metabolism|March 26, 2009
Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodulesYuri E Nikiforov, David L Steward, Toni M Robinson-Smith, et al.
Molecular and Cellular Endocrinology|June 28, 2017
Oncogene-induced senescence and its evasion in a mouse model of thyroid neoplasiaRoberto Bellelli, Donata Vitagliano, Giorgia Federico, et al.
Journal of Surgical Oncology|June 26, 2014
External beam radiotherapy with or without concurrent chemotherapy in advanced or recurrent non-anaplastic non-medullary thyroid cancerPaul B Romesser, Eric J Sherman, Ashok R Shaha, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
Telomerase reactivation induces progression of mouse Braf <sup>V600E</sup> -driven thyroid cancers without telomere lengtheningIñigo Landa, Caitlin Em Thornton, Bin Xu, et al.
Pageof 27

Showing results (171-180 of 261) with videos related to

Sort By:
Pageof 27
BMC Genomics|April 26, 2012
Genome-wide analysis of Pax8 binding provides new insights into thyroid functionsSergio Ruiz-Llorente, Enrique Carrillo Santa de Pau, Ana Sastre-Perona, et al.
Cancer Discovery|February 1, 2013
Relief of feedback inhibition of HER3 transcription by RAF and MEK inhibitors attenuates their antitumor effects in BRAF-mutant thyroid carcinomasCristina Montero-Conde, Sergio Ruiz-Llorente, Jose M Dominguez, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 2012
STAT3 negatively regulates thyroid tumorigenesisJoana Pinto Couto, Laura Daly, Ana Almeida, et al.
Oncogene|August 16, 2024
Cooperative genomic lesions in HRAS-mutant cancers predict resistance to farnesyltransferase inhibitorsAradhya Nigam, Gnana P Krishnamoorthy, Walid K Chatila, et al.
The Journal of Clinical Endocrinology and Metabolism|April 2, 2013
Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancyIan Ganly, Julio Ricarte Filho, Stephanie Eng, et al.
Thyroid : Official Journal of the American Thyroid Association|November 12, 2014
Thyrotropin suppression increases the risk of osteoporosis without decreasing recurrence in ATA low- and intermediate-risk patients with differentiated thyroid carcinomaLaura Y Wang, Andrew W Smith, Frank L Palmer, et al.
The Journal of Clinical Endocrinology and Metabolism|March 26, 2009
Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodulesYuri E Nikiforov, David L Steward, Toni M Robinson-Smith, et al.
Molecular and Cellular Endocrinology|June 28, 2017
Oncogene-induced senescence and its evasion in a mouse model of thyroid neoplasiaRoberto Bellelli, Donata Vitagliano, Giorgia Federico, et al.
Journal of Surgical Oncology|June 26, 2014
External beam radiotherapy with or without concurrent chemotherapy in advanced or recurrent non-anaplastic non-medullary thyroid cancerPaul B Romesser, Eric J Sherman, Ashok R Shaha, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
Telomerase reactivation induces progression of mouse Braf <sup>V600E</sup> -driven thyroid cancers without telomere lengtheningIñigo Landa, Caitlin Em Thornton, Bin Xu, et al.
Pageof 27